help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flenghi, L.
Right arrow Articles by Falini, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flenghi, L.
Right arrow Articles by Falini, B.

American Journal of Pathology, Vol 148, 1543-1555, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region

L Flenghi, B Bigerna, M Fizzotti, S Venturi, L Pasqualucci, S Pileri, BH Ye, M Gambacorta, R Pacini, CD Baroni, E Pescarmona, I Anagnostopoulos, H Stein, G Asdrubali, MF Martelli, PG Pelicci, R Dalla-Favera and B Falini
Institute of Hematology, University of Perugia, Italy.

The human BCL-6 gene, which is rearranged in approximately 30% of diffuse large B cell lymphomas, encodes a 706-amino-acid nuclear protein of the Kruppel-type zinc finger transcription factors mainly expressed in normal germinal center B cells and related lymphomas. Four monoclonal antibodies (PG-B6, PG-B6a, PG-B6p, and PG-B6m), specifically directed against the human BCL-6 protein, were generated by immunizing BALB/c mice with a recombinant protein corresponding to the BCL-6 amino- terminal region (amino acids 3 to 484). The PG-B6 monoclonal antibody reacted with a BCL-6 epitope sensitive to fixatives and preserved in all mammalian species. PG-B6a (a is for avian) recognized the most evolutionarily conserved BCL-6 epitope (expressed in all animal species including avian). PG-B6p (p is for paraffin) recognized a fixative- resistant epitope of BCL-6 that was detectable on paraffin sections after microwave heating in 1 mmol/L EDTA buffer. PG-B6m (m is for mantle) was the least specific monoclonal antibody as, in addition to BCL-6, it reacted with a yet undefined antigen selectively located in the cytoplasm of mantle and marginal zone B cells. All monoclonal antibodies detected strong nuclear expression of BCL-6 in follicular lymphomas, diffuse large B cell lymphomas, Burkitt's lymphomas, and nodular, lymphocyte-predominance Hodgkin's disease. In diffuse large B cell lymphomas, BCL-6 expression was independent of BCL-6 gene rearrangements and did not correlate with expression of other markers or the proliferation index. BCL-6 was not expressed in B-CLL, hairy cell leukemia, mantle-cell- and marginal-zone-derived lymphomas. Labeling of paraffin sections with PG-B6p proved useful for differentiating proliferation centers in B-CLL (BCl-2+/BCL-6-) from trapped germinal centers in mantle cell lymphomas (BCL-2-/BCL-6+) and for identifying neoplastic cells in cases of nodular, lymphocyte- predominance Hodgkin's disease. Because of their high specificity, wide reactivity in humans and animal species including avians (PG-B6a), and suitability for labeling routine paraffin sections (PG-B6p), the reagents described in this paper should prove valuable in both research and diagnostics.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. Carbone, O. A. Botrugno, S. Ronzoni, A. Insinga, L. Di Croce, P. G. Pelicci, and S. Minucci
Recruitment of the Histone Methyltransferase SUV39H1 and Its Role in the Oncogenic Properties of the Leukemia-Associated PML-Retinoic Acid Receptor Fusion Protein
Mol. Cell. Biol., February 15, 2006; 26(4): 1288 - 1296.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. E. Coupland, C. Loddenkemper, J. R. Smith, R. M. Braziel, F. Charlotte, I. Anagnostopoulos, and H. Stein
Expression of Immunoglobulin Transcription Factors in Primary Intraocular Lymphoma and Primary Central Nervous System Lymphoma
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3957 - 3964.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Basso, A. Liso, E. Tiacci, R. Benedetti, A. Pulsoni, R. Foa, F. Di Raimondo, A. Ambrosetti, A. Califano, U. Klein, et al.
Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors
J. Exp. Med., January 5, 2004; 199(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. P. Hans, D. D. Weisenburger, T. C. Greiner, R. D. Gascoyne, J. Delabie, G. Ott, H. K. Muller-Hermelink, E. Campo, R. M. Braziel, E. S. Jaffe, et al.
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Blood, January 1, 2004; 103(1): 275 - 282.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini, E. Tiacci, A. Pucciarini, B. Bigerna, J. Kurth, G. Hatzivassiliou, S. Droetto, B. V. Galletti, M. Gambacorta, A. Orazi, et al.
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT)
Blood, November 15, 2003; 102(10): 3684 - 3692.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Kienle, A. Krober, T. Katzenberger, G. Ott, E. Leupolt, T. F. E. Barth, P. Moller, A. Benner, A. Habermann, H. K. Muller-Hermelink, et al.
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome
Blood, October 15, 2003; 102(8): 3003 - 3009.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Marafioti, S. Ascani, K. Pulford, E. Sabattini, M. Piccioli, M. Jones, P. L. Zinzani, G. Delsol, D. Y. Mason, and S. A. Pileri
Expression of B-Lymphocyte-Associated Transcription Factors in Human T-Cell Neoplasms
Am. J. Pathol., March 1, 2003; 162(3): 861 - 871.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Sanchez-Beato, A. Sanchez-Aguilera, and M. A. Piris
Cell cycle deregulation in B-cell lymphomas
Blood, February 15, 2003; 101(4): 1220 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Linderoth, M. Jerkeman, E. Cavallin-Stahl, S. Kvaloy, and E. Torlakovic
Immunohistochemical Expression of CD23 and CD40 May Identify Prognostically Favorable Subgroups of Diffuse Large B-cell Lymphoma: A Nordic Lymphoma Group Study
Clin. Cancer Res., February 1, 2003; 9(2): 722 - 728.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Wlodarska, P. Nooyen, B. Maes, J. I. Martin-Subero, R. Siebert, P. Pauwels, C. De Wolf-Peeters, and A. Hagemeijer
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma
Blood, January 15, 2003; 101(2): 706 - 710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. A. Pileri, G. Gaidano, P. L. Zinzani, B. Falini, P. Gaulard, E. Zucca, F. Pieri, E. Berra, E. Sabattini, S. Ascani, et al.
Primary Mediastinal B-Cell Lymphoma: High Frequency of BCL-6 Mutations and Consistent Expression of the Transcription Factors OCT-2, BOB.1, and PU.1 in the Absence of Immunoglobulins
Am. J. Pathol., January 1, 2003; 162(1): 243 - 253.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Achten, G. Verhoef, L. Vanuytsel, and C. De Wolf-Peeters
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Distinct Clinicopathologic Entity
J. Clin. Oncol., March 1, 2002; 20(5): 1269 - 1277.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini and D. Y. Mason
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
Blood, January 15, 2002; 99(2): 409 - 426.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Carbone, A. Gloghini, L. M. Larocca, D. Capello, F. Pierconti, V. Canzonieri, U. Tirelli, R. Dalla-Favera, and G. Gaidano
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas
Blood, February 1, 2001; 97(3): 744 - 751.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Hyjek, A. Chadburn, Y. F. Liu, E. Cesarman, and D. M. Knowles
BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus
Blood, January 1, 2001; 97(1): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Falini, M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, et al.
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
Blood, March 15, 2000; 95(6): 2084 - 2092.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Brauninger, R. Kuppers, T. Spieker, R. Siebert, J. G. Strickler, B. Schlegelberger, K. Rajewsky, and M.-L. Hansmann
Molecular Analysis of Single B Cells From T-Cell-Rich B-Cell Lymphoma Shows the Derivation of the Tumor Cells From Mutating Germinal Center B Cells and Exemplifies Means by Which Immunoglobulin Genes Are Modified in Germinal Center B Cells
Blood, April 15, 1999; 93(8): 2679 - 2687.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Carbone, A. Gloghini, L. M. Larocca, A. Antinori, B. Falini, U. Tirelli, R. Dalla-Favera, and G. Gaidano
Human Immunodeficiency Virus-Associated Hodgkin's Disease Derives From Post-Germinal Center B Cells
Blood, April 1, 1999; 93(7): 2319 - 2326.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Cordell, K. A.F. Pulford, B. Bigerna, G. Roncador, A. Banham, E. Colombo, P.-G. Pelicci, D. Y. Mason, and B. Falini
Detection of Normal and Chimeric Nucleophosmin in Human Cells
Blood, January 15, 1999; 93(2): 632 - 642.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Dent, J. Hu-Li, W. E. Paul, and L. M. Staudt
T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6
PNAS, November 10, 1998; 95(23): 13823 - 13828.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Wlodarska, C. De Wolf-Peeters, B. Falini, G. Verhoef, S. W. Morris, A. Hagemeijer, and H. Van denBerghe
The Cryptic inv(2)(p23q35) Defines a New Molecular Genetic Subtype of ALK-Positive Anaplastic Large-Cell Lymphoma
Blood, October 15, 1998; 92(8): 2688 - 2695.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Cesarman, A. Chadburn, Y.-F. Liu, A. Migliazza, R. Dalla-Favera, and D. M. Knowles
BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome
Blood, October 1, 1998; 92(7): 2294 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Falini, B. Bigerna, M. Fizzotti, K. Pulford, S. A. Pileri, G. Delsol, A. Carbone, M. Paulli, U. Magrini, F. Menestrina, et al.
ALK Expression Defines a Distinct Group of T/Null Lymphomas (""ALK Lymphomas"") with a Wide Morphological Spectrum
Am. J. Pathol., September 1, 1998; 153(3): 875 - 886.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Carbone, A. Gloghini, G. Gaidano, R. Dalla-Favera, and B. Falini
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas
Blood, September 15, 1997; 90(6): 2445 - 2450.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti, U. Schneider, D. Huhn, A. Schmidt-Westhausen, P.A. Reichart, U. Gross, et al.
Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection
Blood, February 15, 1997; 89(4): 1413 - 1420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.